Review: taking Marinol and Gabapentin together


Summary

Drug interactions are reported among people who take Marinol and Gabapentin together. This review analyzes the effectiveness and drug interactions between Marinol and Gabapentin. It is created by eHealthMe based on reports of 428 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Marinol

Marinol has active ingredients of dronabinol. It is often used in nausea. (latest outcomes from Marinol 2,513 users)

Gabapentin

Gabapentin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Gabapentin 83,499 users)

On Sep, 15, 2016

428 people who take Marinol, Gabapentin are studied.


Number of reports submitted per year:

Marinol and Gabapentin drug interactions.

Drug effectiveness over time:

Marinol:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Gabapentin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Marinol:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Gabapentin:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Marinol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 0.0% - (0 of 0 people)
Gabapentin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pneumonia
  • seizure
  • weight decreased
  • asthenia
  • atelectasis
  • back pain
  • bacteraemia
  • death
  • diarrhoea
  • drug dependence
1 - 6 months:
  • fever
  • nausea and vomiting
  • stomach pain
  • sweating increased
  • vision blurred
  • vomiting
  • abasia
  • abdominal discomfort
  • amenorrhoea
  • angina pectoris
6 - 12 months:
  • fever
  • insomnia
  • mood swings
  • nausea
  • nausea and vomiting
  • poor dental condition
  • stomach pain
  • sweating increased
  • tired eyes
  • vision blurred
1 - 2 years:
  • cellulitis
  • disease progression
  • erythema
  • hypotension
  • oedema peripheral
  • peripheral swelling
  • pneumonia
  • pulmonary hypertension
  • right ventricular failure
  • chest pain
2 - 5 years:
  • amenorrhoea
  • angina pectoris
  • chest discomfort
  • dizziness
  • drug abuse
  • dysarthria
  • lethargy
  • liver injury
  • overdose
  • renal injury
not specified:
  • nausea
  • pain
  • fatigue
  • vomiting
  • pain in extremity
  • back pain
  • bone disorder
  • headache
  • anaemia
  • osteonecrosis of jaw

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • urinary tract infection
  • vomiting
  • diarrhoea
  • bone disorder
  • depression
  • headache
  • neuropathy peripheral
  • fatigue
male:
  • nausea
  • pain
  • fatigue
  • vomiting
  • asthenia
  • arthralgia
  • weight decreased
  • rash
  • infection
  • pruritus

Most common drug interactions by age *:

2-9:
  • malignant neoplasm progression
  • neuroblastoma
10-19:
  • cardio-respiratory arrest
  • pneumoconiosis
  • vomiting
  • drug abuse
  • drug ineffective
  • abdominal pain
  • acidosis
  • bone density decreased
  • bundle branch block right
  • cardiomyopathy
20-29:
  • pain
  • nausea
  • pulmonary embolism
  • wound haemorrhage
  • dizziness
  • feeling abnormal
  • fatigue
  • fever
  • nausea and vomiting
  • pancytopenia
30-39:
  • nausea
  • pain
  • arthralgia
  • rash
  • asthenia
  • ecchymosis
  • generalised oedema
  • nephrogenic systemic fibrosis
  • oedema peripheral
  • petechiae
40-49:
  • nausea
  • pain
  • constipation
  • back pain
  • osteonecrosis of jaw
  • dysuria
  • urinary tract infection
  • chest pain
  • fatigue
  • bone disorder
50-59:
  • nausea
  • vomiting
  • fatigue
  • diarrhoea
  • pain
  • confusional state
  • pleural effusion
  • asthenia
  • weight decreased
  • dizziness
60+:
  • pain
  • nausea
  • diarrhoea
  • pneumonia
  • anaemia
  • neuropathy peripheral
  • sepsis
  • headache
  • urinary tract infection
  • vomiting

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Marinol and Gabapentin?

Can you answer these questions?

More questions for: Marinol, Gabapentin

You may be interested in these reviews

More reviews for: Marinol, Gabapentin

On eHealthMe, Marinol (dronabinol) is often used to treat nausea. Gabapentin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.